Cabozantinib yields promising intracranial activity with an acceptable safety profile for patients who developed brain metastases from renal cell carcinoma (RCC), according to study results…
View More Cabozantinib Shows Promise for Renal Cell Carcinoma With Brain Metastases
A new STING treatment induces immunological responses that allow the immune system to fight otherwise immunological resistant glioblastoma cancer cells, researchers report A team of…
View More Treatment That May Be Viable For Human Brain Cancer Discovered
While incidence rates of malignant brain cancers have declined over recent years, the five-year survival rate for brain cancer patients remains low A new study…
View More Adult Brain Tumor Incidence Rates Are Decreasing but 5-Year Survival Rates Remain Low
A study revealed that current accuracy of a preoperative clinico‐radiological diagnosis of intracranial tumours is high. A histopathological diagnosis is still favoured in most patients…
View More Current clinico‐radiological diagnostic accuracy for intracranial tumours
Considering cancer as a cofactor for after ischemic stroke outcome may impact clinical decision making. Cancer and stroke represent frequent causes for morbidity and mortality…
View More Cancer leads to an inferior outcome in patients with ischemic stroke
Solitary fibrous tumor (SFT) is a rare mesenchymal tumor that occurs mostly in the pleura. It was first reported and named by Klemperer and Rabin…
View More Malignant Solitary Fibrous Tumor of the Right Cerebellum